Cargando...
Collateral damage: toxic effects of targeted antiangiogenic therapies in ovarian cancer
First-line chemotherapy fails in more than 20% of patients with epithelial ovarian cancer and about 40–50% of women who respond to initial treatment relapse within 2 years. In the recurrent setting, second-line chemotherapeutic agents have a 15–20% response rate with no cures. Fortunately, clinical...
Gardado en:
| Main Authors: | , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
2010
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3199129/ https://ncbi.nlm.nih.gov/pubmed/20226736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1470-2045(09)70362-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|